Anti-MAP3K14 monoclonal antibody

Pre-made anti-MAP3K14 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MAP3K14/MAP3K14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T95736-Ab-1/ GM-Tg-hg-T95736-Ab-2Anti-Human MAP3K14 monoclonal antibodyHuman
GM-Tg-rg-T95736-Ab-1/ GM-Tg-rg-T95736-Ab-2Anti-Rat MAP3K14 monoclonal antibodyRat
GM-Tg-mg-T95736-Ab-1/ GM-Tg-mg-T95736-Ab-2Anti-Mouse MAP3K14 monoclonal antibodyMouse
GM-Tg-cynog-T95736-Ab-1/ GM-Tg-cynog-T95736-Ab-2Anti-Cynomolgus/ Rhesus macaque MAP3K14 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T95736-Ab-1/ GM-Tg-felg-T95736-Ab-2Anti-Feline MAP3K14 monoclonal antibodyFeline
GM-Tg-cang-T95736-Ab-1/ GM-Tg-cang-T95736-Ab-2Anti-Canine MAP3K14 monoclonal antibodyCanine
GM-Tg-bovg-T95736-Ab-1/ GM-Tg-bovg-T95736-Ab-2Anti-Bovine MAP3K14 monoclonal antibodyBovine
GM-Tg-equg-T95736-Ab-1/ GM-Tg-equg-T95736-Ab-2Anti-Equine MAP3K14 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T95736-Ab-1/ GM-Tg-hg-T95736-Ab-2; GM-Tg-rg-T95736-Ab-1/ GM-Tg-rg-T95736-Ab-2;
GM-Tg-mg-T95736-Ab-1/ GM-Tg-mg-T95736-Ab-2; GM-Tg-cynog-T95736-Ab-1/ GM-Tg-cynog-T95736-Ab-2;
GM-Tg-felg-T95736-Ab-1/ GM-Tg-felg-T95736-Ab-2; GM-Tg-cang-T95736-Ab-1/ GM-Tg-cang-T95736-Ab-2;
GM-Tg-bovg-T95736-Ab-1/ GM-Tg-bovg-T95736-Ab-2; GM-Tg-equg-T95736-Ab-1/ GM-Tg-equg-T95736-Ab-2
Products NameAnti-MAP3K14 monoclonal antibody
Formatmab
Target NameMAP3K14
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MAP3K14 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T95736-Ag-1Recombinant multi-species M3K14/ MAP3K14/ FTDCR1B protein


    Target information

    Target IDGM-T95736
    Target NameMAP3K14
    Gene ID9020,53859,360640,716258,490926,101083468,508367,100050140
    Gene Symbol and Synonymsaly,FTDCR1B,HS,HSNIK,MAP3K14,NIK
    Uniprot AccessionQ99558
    Uniprot Entry NameM3K14_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000006062
    Target ClassificationCheckpoint-Immuno Oncology, Kinase

    The target: MAP3K14, gene name: MAP3K14, also named as FTDCR1B, HS, HSNIK, NIK. This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.